11.05.2021 • News

Croda Reviews PTIC businesses

Croda International has announced it is undertaking a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses. The primary aim, said the UK specialty chemicals company, will be to establish what type of ownership structure best serves the businesses going forward and create a stronger platform for its future growth.

The review expected to conclude by the end of 2021 is consistent with Croda’s prioritization of investments in faster-growth life science and consumer markets, which now represent over 80% of the group’s profitability, the company said. Its focus will be on the businesses and activities within PTIC that do not directly support the consumer care and life sciences sectors and will consider whether their full potential can be achieved under Croda, as a standalone business, or through a full or partial divestment.

PTIC’s manufacturing assets include facilities in the UK, The Netherlands, and China. The business focuses on fast-growth markets in the circular plastic economy, electric vehicles and other renewable technologies, supporting the division’s leading market positions in automotive, polymer and food packaging applications.

Author: Elaine Burridge, Freelance Journalist

Croda is undertaking a strategic review of its Performance Technologies and...
Croda is undertaking a strategic review of its Performance Technologies and Industrial Chemicals businesses. The review, expected to conclude by end 2021, will consider whether the businesses will do best under Croda, as a standalone company, or via a full or partial divestment. (c) Croda

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.